FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry

FDA-approved drug repurposing screen identifies inhibitors of SARS-CoV-2 pseudovirus entry

Background and purposeThe coronavirus disease 2019 (COVID-19) pandemic has devastated global health and the economy, underscoring the urgent need for extensive research into the mechanisms of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral entry and the development of effective th...

Full description

Saved in:
Bibliographic Details
Main Authors: Manisha Singh, Shruthi Shanmukha, Raghda E. Eldesouki, Maged M. Harraz
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Pharmacology
Subjects:
SARS-CoV-2
COVID-19
drug repurposing
FDA approved drug library
high-throughput screening
viral entry
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1537912/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1537912/full

Similar Items